Breaking News: Doccla Raises £35 Million to Expand Virtual Bed Technology in Europe
In a world where hospitals face bed shortages, Doccla is revolutionizing healthcare with its "virtual bed" technology. This startup, after gaining success in the U.K. and Ireland, has now secured £35 million in funding to expand its services across Europe. The Series B round is led by Lakestar, with Elaia and existing investors also participating.
Doccla's innovative approach allows doctors to remotely manage patients who have been discharged early or who never step foot in a hospital. This technology not only addresses bed shortages but also supports virtual clinical trials for pharmaceutical companies.
With a focus on hiring local teams in new markets, Doccla is set to make a significant impact in the healthcare industry. By providing monitoring devices and a user-friendly app to patients, the startup ensures data is collected and shared with healthcare providers in real-time.
Doccla's revenue-first strategy and practical market entry tactics have set it apart from its competitors. By expanding into new markets like Germany, Austria, and France, Doccla is poised for continued success.
Furthermore, Doccla's device-agnostic approach and user-friendly interface differentiate it from other virtual hospital solutions in the market. The startup's commitment to innovation and patient care makes it a frontrunner in the healthcare technology sector.
In conclusion, Doccla's groundbreaking technology is reshaping the future of healthcare by offering efficient and cost-effective solutions for patients and healthcare providers alike. By investing in Doccla, individuals can not only support a promising startup but also potentially benefit from its cutting-edge services in the near future.